, illustrate this. None the less, there is good reason to believe that there is a sex-linked abnormality of antibody deficiency syndrome associated with deficiencies of one or more immunoglobulins, though even here there may be qualitative as well as quantitative deficiency of immunoglobulins (Soothill & Rowe 1968) . The association of demonstrable immunity deficiency with odd symptom complexes which are familial, but for which there is no satisfactory unifying hypothesis, provides evidence of recognizable disease entities of genetic cause, such as Aldrich's disease, and immunity deficiency and ataxia telangiectasia. The details of the immunity deficiency syndromes in these diseases (they are probably of the combined type) need further study.
We can therefore make a start in the four-tier system of classification of immunity deficiency states, but the detection of correlations between these systems is only in its infancy. Soothill 
Secondary Antibody Deficiency
The antibody deficiency associated with certain conditions is believed to result somehow from those conditions and has, therefore, been called secondary. After defining criteria, I will consider the incidence and five etiological categories of secondary antibody deficiency.
In 107 normal adults the serum immunoglobulin levels showed a log-normal distribution. The 2 SD ranges in mg/100 ml were yG 500-1,600, yA 125-425, yM 47-170: levels below these limits are called subnormal. Severe hypogammaglobulincemia here follows the MRC ctiterion and is defined as a serum yG level of less than 200 mg/100 ml. At this very low level 70 % of patients are known to suffer excessive infection due to antibody deficiency (Hobbs 1966) . Hypogammaglobulincmia can, of course, be detected by simple serum electrophoresis, but it is possible for an apparently normal y-globulin to be associated with antibody deficiency, a condition for which the term dysgammaglobulinaemia is used. Strictly speaking, this term can only be used when such antibody deficiency has been established after challenging the patient with a series of antigens. In practice , most cases of dysgammaglobulinemia are associated with a severe deficiency of yM and/or yA globulin and, for convenience, dysgammaglobulina?mia will be used here to cover such patients who had yG levels within the normal range. Table 1 shows the incidence of immunoglobulin deficiency found at Hamumersmith Hospital. During the past four years, 20,000 new hospital patients were screened by serum electrophoresis and all sera showing a low y-globulin were checked by immunological measurements. Severe hypogamnmaglobulinmmia was secondary ten times more often than primary and was present in 0-5 %. Subnormal serum yG of secondary type was found in 445 patients, 2 %. For various reasons serum immunoglobulins have been measured in 11,000 patients: dysgammaglobulinaemia was found to be commoner than severe hypogammaglobulinxmia and the secondary forms occurred in 1 % of patients. Secondary immunoglobulin deficiency and probably antibody deficiency was thus found in 3 %, and likely to present as severe infection in over 1 % of hospital patients. That it is indeed common is confirmed by the numbers of cases detected by other workers: 100 by Bernier (1964) , 118 by Claman et al. (1966) and 70 by Andersen & Ward (1966) . The aetiology of secondary antibody deficiency can be considered under the five headings shown in Table 2 . Table 3 shows the numbers studied with details of the subnormal levels found.
Physiological hypogammaglobulinamia mainly occurs in babies born prematurely. It can also occur in those born at full term who for some unknown reason are slow to mature, though this usually affects only yG levels, yA and yM being normal for age. These are common and important Table 3 Incidence of secondary immunoglobulin deficiency Totals of severe yG deficiency (easily detectable by serum electrophoresis; shown on the right) and yM/yA deficiency only (only detected by immunoglobulin assay) within the consecutive series ofnew Hammersmith patients are abstracted in Tables I and 2 *Consecutive cases from MRC myeloma trial together with those found among the 20,000 patients from the Hammersmith Hospital * See footnote to Table 1 causes of severe hypogammaglobulinemia which can be one factor in some cot deaths. Maternal yG is transferred across the placenta during the last trimester of pregnancy. Babies born prematurely get off to a bad start. At twenty weeks gestation they will be at severe risk and up to thirty weeks, although the initial yG level will appear adequate at about 400 mg/100 ml, it is likely to be followed by a severe fall to less than 100 mg/100 ml. Prophylactic y-globulin treatment in such cases can reduce the high incidence of infection (Hobbs & Davis 1967) . The take-over of the normal baby is usually accomplished without a dangerous fall in the yG globulin level, which usually gains adult levels by the age of 3 years. yM globulin matures even faster in nine months and there is some present at birth. yA globulin matures slowly, appearing at about four weeks and not gaining adult levels until puberty. Some infants are slow starters and allow the maternal yG to fall very low. This is much commoner than, and needs to be distinguished from, hereditary inability to make immunoglobulins. As Soothill (1962) pointed out, the genetic defect most commonly causes severe deficiency of all three immunoglobulins whereas those with delayed maturity usually have a normal yM and yA for their age. Where the latter is found the infants can still be tided over with y-globulin treatment but before each dose the yG level should be checked to see if they have started making their own yG. Some of ours have taken up to the age of 5 years before gaining full adult levels, though most have needed only watching or short courses of treatment.
Catabolic hypogammaglobulinwmia is found in diseases with increased turnover of proteins. It is this increased turnover which lowers the yG level, with much less effect on yA or yM. The actual yG-globulin lost in the urine in the nephrotic syndrome is usually less than 1 g daily and cannot account for the failure to maintain a normal yG level, usually requiring the synthesis of only 3 g a day. Andersen (1963) has shown in these diseases that yG catabolism is in fact increased up to 9 g a day: it seems the yG level suffers in the mad drive to increase protein turnover in general. This probably accounts for the low yG seen in severe malnutrition and thoracic duct fistula and it has recently been shown that yG catabolism is increased in dystrophia myotonica (Wochner et al. 1966 ). Probably because the turnover of yG decreases with a falling serum level, severe hypogammaglobulinaemia is not so frequent.
Marrow disorders: In this group Dr M Lewis and I have found a surprisingly high frequency of subnormal yG levels, with little effect on yA or yM levels except in patients dying of cancer. When Askonas & White (1956) accounted for antibodies produced in the guinea-pig, they showed that up to 60% were synthesized within the bone marrow. This could explain much of the fall in yG level seen when the bone marrow is extensively replaced or suppressed and would also explain why yA and yM are not usually so affected. Recently Kaplan et al. (1966) found yM antibodies against yG-globulin in the sera of patients with paroxysmal nocturnal haemoglobinuria and this may be a factor in this subgroup.
Toxic factors: Immunoglobulin deficiency in the fourth group is thought to be the result of toxic factors. Renal failure has long been known to be associated with increased susceptibility to infection. Formerly such patients died, usually with apparently normal y-globulin. Today dialysis and chemotherapy have kept many alive so that falls in the immunoglobulin levels are readily observed. Those with the shorter half-lives, yA 6 days and yM 5 days, fall first and yG follows in a month or two if the renal failure persists. With recovery from uremia all the immunoglobulins usually return to normal levels and I think this clearly implicates a toxic effect of the urtemia. In therapeutic dosage corticosteroids and cytotoxic drugs, even azathioprine, do not commonly result in hypogammaglobulinmmia. It is well known that such treatment (especially combined) predisposes to infection but the mechanism remains obscure. Diazoxide, a new drug used for the treatment of hypoglycemia in childhood, has been shown to depress the yG level though neither in our two patients nor in the published cases (Baker & Miller 1967) are levels reduced to a severe degree.
In a large series of patients with coeliac disease, a depression of yM globulin has been shown (Hobbs & Hepner 1968) . This is particularly so before treatment with a gluten-free diet, whereupon yM recovers and can be depressed again by reintroducing gluten into the diet. This seems to be largely a toxic effect of gluten in these sensitive subjects. For want of a better explanation the few patients with thyrotoxicosis and diabetes mellitus without proteinuria who have had subnormal immunoglobulin levels are classified here although increased catabolism has not been excluded. True transient hypogammaglobulinmmia sometimes occurs in adults: after a previously normal yG level a very low one can be seen with severe infection and can subsequently recover. This seems to be the exception; most patients in fact show the expected increase in immunoglobulins but 3 who were very ill indeed did show a fall, with eventual recovery. These are men- levels; the black areas the mean levels found in patients with malignant reticuloses. In general, deficiency becomes more severe with longer duration of disease, and affects yM more than yA, more than yG tioned to stress that the ill-defined toxaemia of infection can be a very real thing with suppression of normal defence mechanisms. Soothill et al. (1966) have described hypogammaglobulinemia as acquired in utero coincident with rubella and this best accounts for our findings in association with congenital heart disease.
Primary reticuloendothelial neoplasia: This group is the largest. In Table 3 and Fig I malignant reticuloses have been placed in order of increasing incidence and severity of hypogammaglobulinoemia. It is apparent that the longer-lasting diseases such as giant follicular lymphoma and chronic lymphatic leukxemia achieve the lowest levels. Fairley & Scott (1961) clearly showed lower y-globulin levels in patients who had had their chronic lymphatic leukoemia longer. Thymoma may also be very slow to develop; one case took nine years (Wollheim et al. 1964 ). On the other hand, the rapidly fatal reticulosarcoma hardly has time to affect the immunoglobulins. This can be seen in Fig 1 which also shows that, in the other conditions illustrated, yM is affected more than yA, which is in turn affected more than yG; moreover, this is not a reflection of half-life, for yM deficiency can be found months before yA deficiency, which can appear a year or more before yG falls. In patients followed over the four years, I have often observed this sequence develop and in only one patient has yA deficiency been found before yM deficiency. Of the 206 patients shown in Fig 1 180% have had severe infections with pyogenic bacteria and the incidence correlates well with the yG level. Infections occurred in 1 1 of 13 patients with yG <200, 23 of 54 with 200-500 and in 3 of 149 with >500 mg/100 ml. A further 10% have had proven candidiasis or pneumocystis carinii which could not be correlated with yG deficiency, and seemed related to yM deficiency, but the status of cellular immunity was not fully investigated, and this is known to be defective in such patients (Lawler et al. 1967) .
Continuing with this group we come to malignant paraproteinemia and in Table 3 is included the experience afforded by the MRC myeloma trial in addition to that at Hammersmith. The 'severe' groups on the right are therefore expressed as percentages, and only the Hammersmith data were added into the totals in Table I and 2. In myelomatosis severe reductions are most commonly seen with yG paraproteins.
Infection has been a problem in 60% of patients with yG myelomatosis, but in only 33 % with yA and 20% with y,u. These results agree with those of Drivsholm (1964) and correlate closely with severe deficiency of normal immunoglobulins. Some 30% of patients with macroglobulinxmia also suffer excessive infection which cannot be correlated with yG deficiency. Rather it seems that excess yM-globulin can nonspecifically coat the neutrophils and impair phagocytosis (Penny & Galton 1966) . While it is true that the immune paresis associated with reticuloendothelial malignancy can be mediated through defects of the cellular immune responses and also secondary effects on phagocytosis, most of the clinical infections can be correlated to immunoglobulin deficiency. How does this arise?
In about half the patients with yG-myelomatosis it has been shown that the high serum level of yG-paraprotein is associated with increased catabolism of normal yG-globulin and this can result in a lower level of normal yGglobulin (Solomon et al. 1963) . However, in the other half of yG-myelomatosis and with other types (i.e. in 80% of malignant paraproteinmmia) and in chronic lymphatic leukemia it has been established that decreased yG synthesis is responsible (Andersen 1963) . Similarly yM and yA deficiency are mainly due to decreased synthesis (Barth et al. 1964 ).
How does this suppression of normal immunoglobulin synthesis occur? Simple displacement of the normal plasma cells by neoplastic cells seems unlikely, because in the marrow this would also result in leucoerythroblastic anxmia, which in fact is found in less than 50% of these patients.
Marrow occupation would also depress yG first, as shown in Group C, whereas this is usually the last to fall. Furthermore, yA is largely derived from the gut which is rarely directly involved by tumour. It has also been suggested that the neoplastic cells misappropriate available amino acids at the expense of normal plasma cells. Immunoglobulin deficiency is, however, unusual with most other types of neoplasia and even among the reticuloendothelial malignancies it cannot be correlated with the extent of the tumour. These theories also fall down with localized tumours which can be associated with immunoglobulin deficiency. In two patients removal of an apparently solitary myeloma was found to restore immunoglobulin levels to normal (Hobbs 1966) . In 2 other patients with severe hypogammaglobulinemia (yG 160, 140 mg/100 ml) and gross splenomegaly, splenectomy was followed by recovery of yG levels (500, 800 mg/100 ml). In these 2 cases, which are very much the exception, histology revealed giant follicular lymphomatosis of the spleen, quite distinct from the hyperplasia typical of adult hypogammaglobulinemia. Neither patient has yet shown metastases at two and three years respectively. The findings in the above 4 patients suggest that reticuloendothelial tumouis can release some humoral substance which can inhibit the synthesis of normal immunoglobulins.
Throughout the above discussion it has been assumed the reticuloendothelial malignancy came first, and indeed the picture of worsening hypogammaglobulinemia with longer duration of disease suggests this is the usual pattern. However, it is also possible that hypogammaglobulinaemia itself results in overstimulation of the cellular mechanisms of immunity to a degree increasing the risk of neoplastic mutation. Recently Fudenberg (1966) has reviewed the evidence which supports the belief that antibody deficiency can sometimes be primary to reticuloendothelial neoplasia.
In summary, secondary immunoglobulin deficiency is much commoner than the primary types and an important mechanism for symptoms in 1 % of hospital patients. It can be classified into five rtiological categories the first three of which largely affect only yG levels, the latter two characteristically reducing yM initially, then yA and finally yG. Diagnosis and treatment with y-globulin is especially rewarding in the physiological group and can be helpful with marrow disorders and with the more slowly progressive reticuloendothelial malignancy.
